Search Results - "van Gorp, P J"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice by de Winther, Menno P.J., Gijbels, Marion J.J., van Dijk, Ko Willems, van Gorp, Patrick J.J., Suzuki, Hiroshi, Kodama, Tatsuhiko, Frants, Rune R., Havekes, Louis M., Hofker, Marten H.

    Published in Atherosclerosis (01-06-1999)
    “…Apolipoprotein (apo) E3Leiden is a dysfunctional apo E variant associated with familial dysbetalipoproteinemia in humans. Transgenic mice carrying the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis by van Hogezand, R A, van Hees, P A, van Gorp, J P, van Lier, H J, Bakker, J H, Wesseling, P, van Haelst, U J, van Tongeren, J H

    Published in Alimentary pharmacology & therapeutics (01-02-1988)
    “…Suppositories containing 300 mg 5-aminosalicylic acid (1.96 mmol) or 425 mg acetyl-5-aminosalicylic acid (1.96 mmol) were used in 40 patients with idiopathic…”
    Get more information
    Journal Article
  5. 5

    Cathepsin D regulates lipid metabolism in murine steatohepatitis by Houben, Tom, Oligschlaeger, Yvonne, Hendrikx, Tim, Bitorina, Albert V., Walenbergh, Sofie M. A., van Gorp, Patrick J., Gijbels, Marion J. J., Friedrichs, Silvia, Plat, Jogchum, Schaap, Frank G., Lütjohann, Dieter, Hofker, Marten H., Shiri-Sverdlov, Ronit

    Published in Scientific reports (14-06-2017)
    “…Due to the obesity epidemic, non-alcoholic steatohepatitis (NASH) is a prevalent liver disease, characterized by fat accumulation and inflammation of the…”
    Get full text
    Journal Article
  6. 6

    Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates by Shiri-Sverdlov, Ronit, Wouters, Kristiaan, Gorp, Patrick J. van, Gijbels, Marion J., Noel, Benoit, Buffat, Laurent, Staels, Bart, Maeda, Nobuyo, Bilsen, Marc van, Hofker, Marten H.

    Published in Journal of hepatology (01-04-2006)
    “…The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fully understood. In mice, NASH can be inhibited by fenofibrate, a synthetic…”
    Get full text
    Journal Article
  7. 7

    Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice by Wouters, Kristiaan, Shiri-Sverdlov, Ronit, van Gorp, Patrick J, van Bilsen, Marc, Hofker, Marten H

    Published in Clinical chemistry and laboratory medicine (01-01-2005)
    “…Hyperlipidemia is the most important risk factor for atherosclerosis, which is the major cause of cardiovascular disease. The etiology of hyperlipidemia and…”
    Get more information
    Journal Article
  8. 8
  9. 9